Capital Advisors Ltd’s Epizyme, Inc EPZM Stock Holding History

Capital Advisors Ltd’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-268	Closed	–	–	1645
2022 Q2	$0	Buy	+268	New	+$197	﹤0.01%	1460

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Capital Advisors Ltd's EPZM Position: Q3 2022 in Review

Capital Advisors Ltd sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 268 shares.

Capital Advisors Ltd first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Capital Advisors Ltd reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Capital Advisors Ltd sold 268 Epizyme, Inc shares in Q3 2022.
Capital Advisors Ltd first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Capital Advisors Ltd's Epizyme, Inc position peaked at $0 in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Capital Advisors Ltd's 13F filing for Q3 2022, filed 9 Nov 2022.